Osteonecrosis of the tibia associated with imatinib in metastatic GI stromal tumor

J Clin Oncol. 2013 Jun 1;31(16):e248-50. doi: 10.1200/JCO.2012.45.1294. Epub 2013 Apr 8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Benzamides / administration & dosage
  • Benzamides / adverse effects*
  • Disease Progression
  • Drug Administration Schedule
  • Female
  • Gastrointestinal Neoplasms / diagnosis
  • Gastrointestinal Neoplasms / drug therapy*
  • Gastrointestinal Neoplasms / pathology
  • Gastrointestinal Stromal Tumors / diagnosis
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / secondary
  • Humans
  • Imatinib Mesylate
  • Incidental Findings
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Middle Aged
  • Osteonecrosis / chemically induced*
  • Osteonecrosis / complications
  • Pain / etiology
  • Peritoneal Neoplasms / drug therapy*
  • Peritoneal Neoplasms / secondary
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects*
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*
  • Range of Motion, Articular
  • Tibia / drug effects*
  • Tibia / pathology

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate